FRANKLIN LAKES, N.J., Aug. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest more than $35 million ...
Due to advances in technology and increased development of parenteral drugs, one of the fastest growing choices for drug delivery in the pharmaceutical industry is the prefilled syringe (PFS). Not ...
BD, a leading global medical technology company, is investing more than $35 million to expand prefilled flush syringe manufacturing at its Columbus, Neb., facility. With the investment, the company ...
Sharps Technology Inc. (NASDAQ: STSS) is pushing into the copolymer prefillable syringe market thanks to a deal with Nephron Pharmaceuticals Corp., a leader in contract manufacturing of generic ...
DUBLIN--(BUSINESS WIRE)--The "Prefilled Syringes - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Prefilled Syringes was estimated ...
The U.S. Food and Drug Administration has approved GSK's prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted) for the prevention of shingles (herpes zoster). The ...
Dublin, May 11, 2026 (GLOBE NEWSWIRE)-- The "Prefilled Syringes Market by Type, Material, Design, Application, & Region - Global Forecast to 2031" has been added to ResearchAndMarkets.com's offering.
The global Prefilled Syringes Market is projected to expand at a strong single-digit growth rate through 2027. This growth is primarily fueled by the rising burden of chronic diseases, increasing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results